Anticancer drugs
 Add to favourites!!!

Anticancer drugs






Anticancer drugs

  Abstract TEMPLATE
  Download the program as PDF






Advisory Board Member

Sabry M. Attia, M.Sc.,Ph.D.,

Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia












Dr. Sabry M. Attia is an associate professor at the department of Pharmacology and Toxicology, College of Pharmacy, Al-Azhar University and currently works as a professor in College of Pharmacy, King Saud University. He received his M.Sc. in Pharmacology and Toxicology from Al-Azhar University, Egypt and his Ph.D. in Genetics at Technical University of Munich, Germany in 2000-2004. Dr. Attia also has worked at GSF-Institute of Experimental Genetics, Germany from the period of May, 2002 to September, 2004 as a postdoctoral research associate and from in 2007 as a postdoctoral fellowship in Jerzy Adamski’s group at GSF-Institute of Genome Analysis Center, Germany. This period of research was concerned with developing new approaches for drug screening, toxicants detection and prevention. He has contributed to number of journals interested in the area of Molecular Pharmacology and Toxicology. During his scientific career, Dr. Attia has developed an expertise in several advanced techniques and research protocols related to Molecular pharmacology and toxicology. Dr. Attia attended multiple courses on research methodology as well as biostatistics.  Dr. Attia has more than forty publications in peer-reviewed international journals. Dr. Attia was awarded “State Prize for Encouragement of Scientific Research” in Medical Sciences, the Academy of Scientific Research and Technology, Cairo, Egypt, 2010 and the second prize for the best 2 presentations at the Anticancer Drug Conference 2011. Held in Stockholm, Sweden. October 26-27, 2011.




Anticancer drugs

Anticancer drugs conferences 2011 2013                                        Powered by